Biomarkers: Diabetes, Obesity and Heart
Molecular Biomarkers can be differentiated as a measurable indicator. It is precisely estimated and checked as a pointer of normal biological procedures, pathogenic techniques, or pharmacologic reactions to a pharmaceutical intervention. Biomarkers have an important role in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals to gain knowledge and apply the cognition to scientifically valid decisions. More efficient revelation and use of biomarkers in the development of anti-diabetic drugs will rely upon accelerating our comprehension of the pathogenesis of diabetes and particularly its macrovascular complications. Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.